Skip to playerSkip to main content
  • 2 hours ago
AI diagnostic technologies are now showcasing superior accuracy in identifying early-stage cancers, such as breast and skin cancer, compared to the performance of trained doctors in various clinical trials. This has led American hospitals to confront issues regarding implementation, liability, and patient consent.

Category

πŸ—ž
News
Transcript
00:00Artificial intelligence is now diagnosing certain cancers faster and more accurately than trained physicians.
00:06And American hospitals are deeply divided about whether to trust it with patients' lives.
00:12New clinical data shows that AI diagnostic systems can detect early-stage breast cancer in mammograms,
00:18with accuracy rates exceeding those of radiologists.
00:21Similar performance has also been documented in skin cancer detection.
00:26Colon polyp identification during colonoscopies.
00:30And diabetic eye disease screening.
00:32The promise is enormous. Earlier detection saves lives.
00:36Reduced doctor workload helps address a critical physician shortage.
00:41AI could also reach rural and underserved American communities that currently have no access to specialist doctors.
00:48But the concerns are equally serious.
00:50Who is liable when AI gets it wrong?
00:53How do patients consent to AI diagnosis?
00:56And what happens when the system is wrong?
00:58Quietly, confidently, with no human to challenge it.
01:02Leading U.S. hospital networks are beginning to integrate these tools while still keeping doctors in the loop.
01:09The FDA has already approved more than 500 AI-enabled medical devices.
01:14But regulation of AI diagnostic tools in clinical settings remains fragmented and inconsistent.
01:20For millions of Americans, the question is no longer theoretical.
01:25AI may already be reading your next scan.
01:27We are going to research on ΕΌy CRISPR doangin,nor,şiven,hdhdd,Γͺ,d,andxpurs taburopel,wad ellesd,dveiwad accu.
Comments

Recommended